AI channel feed

Health tech start­up Com­mure bets on AI for med­ical notes in $139M deal

11 months ago
Startups
Deals

Where Oak HC/FT in­vestor Nan­cy Brown is plac­ing her bets on AI in health tech

11 months ago
Startups
Health Tech

With a $372M megaround, For­ma­tion Bio looks to in-li­cense 10+ drugs

12 months ago
Financing

Lil­ly be­comes the lat­est phar­ma to tap Ope­nAI for help, this time for an­tibi­ot­ic work

12 months ago
R&D
Pharma

Ex-Meta sci­en­tists launch Evo­lu­tion­aryScale with $142M seed round, un­veil­ing next-gen AI mod­el for pro­tein de­sign

12 months ago
Financing
Startups

The End­points Slack in­ter­view: Saji Wick­ra­masekara on where AI miss­es the mark — and what's next for Bench­ling

Last year
In Focus
Health Tech

Obe­si­ty care start­up known­well buys an AI weight loss plat­form

Last year
Deals
Health Tech

How two aca­d­e­m­ic chemists turned San Diego start­up Iambic in­to an AI force

Last year
In Focus

AI drug dis­cov­ery start­up goes pub­lic in Hong Kong, nab­bing $115M to build on phar­ma part­ner­ships

Last year
Financing
China

AI is un­like­ly to take off among CD­MOs at the same scale as bio­phar­ma com­pa­nies, in­sid­ers say

Last year
Manufacturing

Ex­clu­sive: In­spired by Spin­raza, start­up rais­es $25M for can­cer drug tar­gets cre­at­ed by al­ter­na­tive RNA splic­ing

Last year
Financing

Mer­ck KGaA con­tin­ues AI drug dis­cov­ery deal spree with Bi­olo­jic De­sign 

Last year
Deals

Sanofi, Ope­nAI, For­ma­tion Bio an­nounce AI drug de­vel­op­ment part­ner­ship

Last year
Deals
R&D

AI biotech Ex­sci­en­tia to trim near­ly a quar­ter of work­force, fol­low­ing pipeline cut and CEO fir­ing

Last year
People

The End­points Slack in­ter­view: Sid­dhartha Mukher­jee on the doc­tor-writer world­view, AI, and the fu­ture of can­cer

Last year
R&D
In Focus

Ex­clu­sive: Har­vard start­up rais­es $26M, strikes three phar­ma part­ner­ships for AI an­ti­body de­sign

Last year
Deals

'Big­ger, faster, bet­ter': Iso­mor­phic, Deep­Mind un­veil Al­phaFold 3, go­ing be­yond pro­tein pre­dic­tions

Last year
R&D

The next gen­er­a­tion of AI biotechs is here. Can they de­liv­er on the hype?

Last year
R&D

Ex­clu­sive: Marc Tessier-Lav­i­gne on leav­ing Stan­ford and join­ing biotech’s new AI mega-start­up

Last year
People
Startups

Why VC leg­end Bob Nelsen is mak­ing the biggest ini­tial bet of his 37-year ca­reer on Xaira

Last year
People
Startups

AI drug dis­cov­ery start­up Benev­o­len­tAI cuts 30% of staff, clos­es US of­fice 

Last year
People

A ma­jor­i­ty of phar­ma and biotech com­pa­nies pro­hib­it Chat­G­PT use, sur­vey finds

Last year
Pharma

Cash, chips and tal­ent: In­side Nvidi­a's plan to dom­i­nate biotech's AI rev­o­lu­tion

Last year
R&D
In Focus

Ex­clu­sive: Ex-Re­cur­sion team launch­es Leash Bio, chal­leng­ing AI field with its bet on need­ing more da­ta

Last year
Financing
First page Previous page 2345678 Next page Last page
A service from the Financial Times